Aura Biosciences, Inc.AURANASDAQ

Revenue (LTM)

Net Income (LTM)

$-87M

-13.8% YoY

Free Cash Flow

$-81M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	0	0	0	0	0
Gross Profit	0	0	0	-1	0
Operating Income	-22	-35↓58.7%	-60↓71.0%	-85↓41.0%	-96↓13.1%
Net Income	-22	-35↓58.7%	-59↓66.7%	-76↓30.0%	-87↓13.8%
EBITDA	-21	-34↓61.0%	-59↓71.8%	-84↓41.6%	-95↓13.4%
EPS Diluted	-1.03	-1.58↓53.4%	-1.96↓24.1%	-1.93↑1.5%	-1.75↑9.3%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	17	149↑757.0%	122↓18.4%	41↓66.2%	32↓22.8%
Total Current Assets	18	154↑732.9%	197↑28.0%	232↑17.8%	161↓30.7%
Total Assets	22	160↑624.0%	224↑39.9%	255↑13.9%	183↓28.5%
Total Current Liabilities	3	7↑176.4%	10↑42.2%	12↑18.2%	15↑20.7%
Total Liabilities	3	8↑181.5%	28↑267.5%	29↑3.1%	31↑4.5%
Total Equity	19	152↑686.6%	196↑28.4%	226↑15.5%	152↓32.7%
Total Debt	0	1↑6400.0%	21↑2039.3%	20↓6.2%	19↓4.0%
Net Debt	-17	-148↓752.2%	-101↑32.0%	-22↑78.6%	-13↑39.9%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-24	-32↓33.3%	-55↓68.5%	-64↓16.9%	-80↓25.0%
Capital Expenditure	-1	-2↓175.6%	-1↑48.5%	-1↑35.2%	-1↓76.7%
Free Cash Flow	-25	-35↓37.6%	-56↓61.3%	-65↓15.9%	-81↓25.6%
Stock-Based Comp	1	2↑213.5%	6↑177.9%	9↑36.8%	12↑33.6%
Net Change in Cash	-15	132↑974.9%	-27↓120.4%	-81↓200.0%	-9↑88.3%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance